Results 261 to 270 of about 765,049 (358)

Outcomes with venoarterial vs venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation in interstitial lung disease

Prasanth Balasubramanian, Pablo Moreno Franco, Sanjay Chaudhary, Francisco Alvarez, M. Baz, Tathagat Narula, Sadia Shah, Mohammad Alomari, R. Bongu, Anirban Bhattacharyya, Devang Sanghavi, Sean Kiley, Archer Kilbourne Martin, Nikki Matos, John C. Haney, Ian A. Makey, Mathew Thomas, Pramod Guru, Remzi Bag   +18 more
openalex   +2 more sources

Population Pharmacokinetics and Exposure‐Response Analysis of First‐Line Osimertinib Plus Chemotherapy in Patients with EGFR‐Mutated Advanced NSCLC

Clinical Pharmacology &Therapeutics, EarlyView.
Osimertinib, a third‐generation, central nervous system‐active epidermal growth factor receptor‐tyrosine kinase inhibitor, potently and selectively inhibits epidermal growth factor receptor‐tyrosine kinase inhibitor sensitizing and T790M resistance mutations, with efficacy in epidermal growth factor receptor‐mutated non‐small cell lung cancer.
Jincheng Yang, Damilola Olabode, Aarti Sawant‐Basak, Richard Baldry, Karthick Vishwanathan, Srinivas Bachina, Alexandar Todd, Dana Ghiorghiu, Yuri Rukazenkov, Diansong Zhou, Azar Shahraz   +10 more
wiley   +1 more source

Global epidemiology and burden of interstitial lung disease. [PDF]

Lancet Respir Med
Spagnolo P, Guler SA, Chaudhuri N, Udwadia Z, Sesé L, Kaul B, Enghelmayer JI, Valenzuela C, Malhotra A, Ryerson CJ, Khor YH, Corte TJ, Cottin V.   +12 more
europepmc   +1 more source

ABS0261 ALTERED TRYPTOPHAN PATHWAY METABOLISM AND ASSOCIATION WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5 POSITIVE DERMATOMYOSITIS

Huiqing Liu, Ye Guo, Xinyu Dai, J Zhang, Qingmei Xie   +4 more
openalex   +1 more source

Foundational Principles for the Quantitative Translation of T‐Cell Therapeutics for Hematologic Malignancies and Immunology

Clinical Pharmacology &Therapeutics, EarlyView.
T‐cell engaging antibodies (TCEs) and chimeric antigen receptor (CAR) T cells (CAR‐T cells) are among precision medicine therapies that have revolutionized the treatment of hematologic cancers. Their success in oncology has piqued interest in translating this promise into additional indications, such as autoimmune disorders.
Peter Ashcroft, Sarah McFann, Alex Ferguson, Arthur Van De Vyver, Suzanne Gaudet, Eshita Khera, Jan‐Frederik Schlender   +6 more
wiley   +1 more source

Case Report: Hydroxychloroquine in an infant with <i>NKX2-1</i>-associated interstitial lung disease. [PDF]

Front Pediatr
Qing D, Xu X, Shi T, Fan H, Zhang D, Yang D, Lu G.   +6 more
europepmc   +1 more source

OP0044 Interstitial lung disease associated with Sjögren's disease (SjD-ILD) is frequently progressive across all high-resolution computed tomography (HRCT) patterns

M. Sprecher, Kastriot Kastrati, Danilo Bruni, B. Müller-Durovic, Thomas Frauenfelder, Christian F. Clarenbach, Ellen Melbye Langballe, Håvard Fretheim, N. Moe, H. Andersson, P.P. Diep, Ø. Molberg, Cathrine Brunborg, Trond Mogens Aaløkken, P. Studenic, Helmut Prosch, H. Lechner-Radner, O. Distler, A.M. Hoffmann-Vold   +18 more
openalex   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Diagnostic yield and safety of transbronchial lung cryobiopsy using 1.7-mm probes in interstitial lung disease

Ai Koike, Kazuya Tsubouchi, Satoshi Nakamura, T. Takano, Mikiko Hashisako, Takuya Hino, Hidetake Yabuuchi, Isamu Okamoto   +7 more
openalex   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source